Abstract |
A key step in the Fanconi anemia (FA) tumor suppressor pathway is the site-specific monoubiquitination of the FANCD2 protein. Genetic studies indicate that this crucial modification requires eight known FA gene products and the E2-conjugating enzyme Ube2t. Here, we minimally reconstitute this monoubiquitination reaction with Ube2t and the FANCL protein, revealing that monoubiquitination is stimulated by a conserved RWD-like domain in FANCL. Furthermore, addition of the FANCI protein enhances monoubiquitination and also restricts it to the in vivo substrate lysine residue on FANCD2. This work therefore establishes a system that provides mechanistic insight into the functions of FANCL and FANCI in the catalysis of FANCD2 monoubiquitination.
|
Authors | Arno F Alpi, Paul E Pace, M Madan Babu, Ketan J Patel |
Journal | Molecular cell
(Mol Cell)
Vol. 32
Issue 6
Pg. 767-77
(Dec 26 2008)
ISSN: 1097-4164 [Electronic] United States |
PMID | 19111657
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- FANCI protein, human
- Fanconi Anemia Complementation Group D2 Protein
- Fanconi Anemia Complementation Group Proteins
- UBE2T protein, human
- UBE2W protein, human
- Ubiquitin-Conjugating Enzymes
- Fanconi Anemia Complementation Group L Protein
|
Topics |
- Amino Acid Sequence
- Animals
- Cell Line
- Chickens
- Conserved Sequence
- Fanconi Anemia Complementation Group D2 Protein
(metabolism)
- Fanconi Anemia Complementation Group L Protein
(chemistry, metabolism)
- Fanconi Anemia Complementation Group Proteins
(metabolism)
- Humans
- Molecular Sequence Data
- Protein Structure, Tertiary
- Substrate Specificity
- Ubiquitin-Conjugating Enzymes
(metabolism)
- Ubiquitination
|